Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.

Hashizume A

doi:10.1111/iju.70262

← 뒤로

Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.

사설/논평 0/5 보강

International journal of urology : official journal of the Japanese Urological Association 📖 저널 OA 27.2% 2021~2026 2025 Vol.32(12) p. 1864-1865

Hashizume A

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Hashizume A (2025). Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.. International journal of urology : official journal of the Japanese Urological Association, 32(12), 1864-1865. https://doi.org/10.1111/iju.70262

MLA Hashizume A. "Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.." International journal of urology : official journal of the Japanese Urological Association, vol. 32, no. 12, 2025, pp. 1864-1865.

PMID 41249868 ↗

DOI 10.1111/iju.70262

같은 제1저자의 인용 많은 논문 (1)

Comparative Effectiveness of First-Line Treatments for Castration-Resistant Prostate Cancer: A Large-Scale Retrospective Study in Japan.
The Prostate 2025